Immunocapture-based fluorometric assay for the measurement of insulin-degrading enzyme activity in brain tissue homogenates

Journal of Neuroscience Methods

Volumn 169, Issue 1, 2008, Pages 177-181

  Miners, James Scott ^a   Kehoe, Patrick Gavin ^a   Love, Seth ^a  

^a Institute of Clinical Neurosciences   (United Kingdom)

Author keywords

Alzheimer's disease; Fluorogenic substrate; Immunocapture; Insulin degrading enzyme; Insulin dependent diabetes

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN CONVERTING ENZYME; INSULINASE; MEMBRANE METALLOENDOPEPTIDASE;

ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; BRAIN TISSUE; CONTROLLED STUDY; ENZYME ACTIVITY; FLUOROMETRY; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; BINDING SITES; BRAIN; BRAIN CHEMISTRY; CROSS REACTIONS; DIABETES MELLITUS, TYPE 1; FLUORESCENT ANTIBODY TECHNIQUE; FLUORESCENT DYES; FLUOROIMMUNOASSAY; HUMANS; INSULYSIN; NEUROCHEMISTRY; PEPTIDES; PREDICTIVE VALUE OF TESTS; RATS; REPRODUCIBILITY OF RESULTS; SUBCELLULAR FRACTIONS; SUBSTRATE SPECIFICITY;

EID: 39749194421     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2007.12.003     Document Type: Article

References (22)

1. Affholter J.A., Hsieh C.L., Francke U., and Roth R.A. Insulin-degrading enzyme: stable expression of the human complementary DNA, characterization of its protein product, and chromosomal mapping of the human and mouse genes. Mol Endocrinol 4 (1990) 1125-1135
2. Akiyama H., Shii K., Yokono K., Yonezawa K., Sato S., Watanabe K., et al. Cellular localization of insulin-degrading enzyme in rat liver using monoclonal antibodies specific for this enzyme. Biochem Biophys Res Commun 155 (1988) 914-922
3. Authier F., Cameron P.H., and Taupin V. Association of insulin-degrading enzyme with a 70 kDa cytosolic protein in hepatoma cells. Biochem J 319 Pt. 1 (1996) 149-158
4. Bennet R., Eriksson M., Nord C.E., and Tafari N. Transient asymptomatic colonisation of newborn Ethiopian infants by Salmonella. Infection 22 (1994) 49-50
5. Bennett R.G., Duckworth W.C., and Hamel F.G. Degradation of amylin by insulin-degrading enzyme. J Biol Chem 275 (2000) 36621-36625
6. Cook D.G., Leverenz J.B., McMillan P.J., Kulstad J.J., Ericksen S., Roth R.A., et al. Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele. Am J Pathol 162 (2003) 313-319
7. Duckworth W.C., Bennett R.G., and Hamel F.G. A direct inhibitory effect of insulin on a cytosolic proteolytic complex containing insulin-degrading enzyme and multicatalytic proteinase. J Biol Chem 269 (1994) 24575-24580
8. Duckworth W.C., Bennett R.G., and Hamel F.G. Insulin degradation: progress and potential. Endocr Rev 19 (1998) 608-624
9. Farris W., Mansourian S., Chang Y., Lindsley L., Eckman E.A., Frosch M.P., et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 100 (2003) 4162-4167
10. Goldfine I.D., Williams J.A., Bailey A.C., Wong K.Y., Iwamoto Y., Yokono K., et al. Degradation of insulin by isolated mouse pancreatic acini, evidence for cell surface protease activity. Diabetes 33 (1984) 64-72
11. Kirschner R.J., and Goldberg A.L. A high molecular weight metalloendoprotease from the cytosol of mammalian cells. J Biol Chem 258 (1983) 967-976
12. Kuo W.L., Montag A.G., and Rosner M.R. Insulin-degrading enzyme is differentially expressed and developmentally regulated in various rat tissues. Endocrinology 132 (1993) 604-611
13. Kurochkin I.V., and Goto S. Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett 345 (1994) 33-37
14. Leissring M.A., Farris W., Chang A.Y., Walsh D.M., Wu X., Sun X., et al. Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40 (2003) 1087-1093
15. Miners J.S., Verbeek M., Rikkert M.O., Kehoe P.G., and Love S. Immunocapture-based fluorometric assay for the measurement of neprilysin-specific enzyme activity in brain tissue homogenates and cerebrospinal fluid. J Neurosci Methods 167 (2008) 229-236
16. 125I]monoiodoinsulin. Diabetes 38 (1989) 152-158
17. Morita M., Kurochkin I.V., Motojima K., Goto S., Takano T., Okamura S., et al. Insulin-degrading enzyme exists inside of rat liver peroxisomes and degrades oxidized proteins. Cell Struct Funct 25 (2000) 309-315
18. Perez A., Morelli L., Cresto J.C., and Castano E.M. Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains. Neurochem Res 25 (2000) 247-255
19. Qiu W.Q., Walsh D.M., Ye Z., Vekrellis K., Zhang J., Podlisny M.B., et al. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem 273 (1998) 32730-32738
20. Seta K., Hayashi T., Sugawara A., Kasuno K., Watanabe S., Sumi Y., et al. Atrial natriuretic peptide as a preload depressor in acute renal failure secondary to congestive heart failure. Ren Fail 20 (1998) 717-723
21. Vekrellis K., Ye Z., Qiu W.Q., Walsh D., Hartley D., Chesneau V., et al. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J Neurosci 20 (2000) 1657-1665
22. Zhao Z., Xiang Z., Haroutunian V., Buxbaum J.D., Stetka B., and Pasinetti G.M. Insulin degrading enzyme activity selectively decreases in the hippocampal formation of cases at high risk to develop Alzheimer's disease. Neurobiol Aging 28 (2007) 824-830